American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • American Pharmacy News Reports

PharmaCyte Biotech to receive 2017 Buzz of BIO award

Carrie Bradon | May 3, 2017
Among topics to be discussed will be drug discovery, biomanufacturing, biofuels and cell therapy.

PharmaCyte Biotech, Inc., announced that they would be winning the 2017 Buzz of BIO "Pipelines of Promise" award prior to the 2017 BIO International Convention. Read More »

Biopharma Corp. wraps up latest acne product trial

American Pharmacy News Reports | May 3, 2017
BPX-01[1] is a “non-oil-based topical gel with fully solubilized minocycline.

BioPharmX Corp., a leading pharmaceutical company developing and promoting health products for the dermatology and women’s market, revealed it has completed the “last subject visit in its Phase 2b trial,” as of March. Read More »

DelMar decreases public holdings by $700,000

American Pharmacy News Reports | May 3, 2017
DelMar intends to use the net proceeds from the offering for general corporate purposes.

DelMar Pharmaceuticals Inc., a company fighting for cancer patients and therapies, decreased its public stock aggregate share from 2.77 million to 2.08 million this month. Read More »

Amgen, Novartis seek cure for Alzheimer's-related migraines

American Pharmacy News Reports | May 2, 2017
Amgen will receive payments from Novartis beginning this year, as the companies share costs.

Amgen and Novartis are working together to fight against migraines with erenumab, an expanded commercial collaboration building on a global neuroscience collaboration in Alzheimer's disease and migraine established in 2015. Read More »

New medication from Teva available for asthma treatment

American Pharmacy News Reports | May 2, 2017
AirDuo RespiClick was approved by the FDA in January in three dosage options: 55/14 mcg, 113/14 mcg and 232/14 mcg.

Teva Pharmaceutical Industries Ltd. has launched AirDuo RespiClick, an inhalation powder for the treatment of asthma in patients 12 and older. Read More »

Kmart Pharmacy offers reduced pricing for epinephrine pens

American Pharmacy News Reports | May 2, 2017
The generic version of Adrenaclick is now available for free for patients with commercial insurance.

To make health care more affordable for those who need it, Kmart Pharmacy is reducing the price of epinephrine auto-injector pens. Read More »

Martin to join Purdue Pharma as VP of corporate affairs

Carrie Bradon | May 2, 2017
Josie Martin has held positions at Ketchum, the Federation of American Hospitals and the American Red Cross.

Josie Martin has been named vice president of corporate affairs and communications for Purdue Pharma LP. Read More »

Whistleblowers encouraged to deliver accurate information

American Pharmacy News Reports | May 2, 2017
Whistleblowing could prevent injuries and yield rewards for individuals.

The Corporate Whistleblower Center is encouraging individuals to reach out to authorities if they know of unsanitary pharmacy practices. Read More »

Pharmacy Benefits Managers can be more affordable option than drugstores

American Pharmacy News Reports | May 1, 2017
The new agenda of drugstores would seek to increase their profit, while costing consumers more.

The Pharmaceutical Care Management Association is beginning the DrugBenefitSolutions national campaign, in which it seeks to explain how pharmacy benefits managers are helping to reduce the price of medications and assist consumers, as well as employers and unions. Read More »

Biologics chosen as specialty pharmacy provider for ZEJULA

Carrie Bradon | May 1, 2017
The American Cancer Society states that there are more than 22,000 women who will be diagnosed with ovarian cancer this year.

Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by Tesaro Inc. to provide its new drug. Read More »

Purdue Pharma welcomes new OTC business lead

American Pharmacy News Reports | May 1, 2017
Carrie Chomiak will work with the company's OTC assets, development, implementation, communication and more.

Purdue Pharma LP's Carrie Chomiak will be stepping up into a substantial business role as lead of over-the-counter product franchise for brands including Betadine microbicide antiseptics, Slow-Mag magnesium chloride supplements, Senokot laxative and Colace stool softener. Read More »

Shire publishes results of lanadelumab study in New England Journal of Medicine

American Pharmacy News Reports | May 1, 2017
In this Phase 1b study, no serious adverse events or discontinuations due to adverse events were observed at all doses studied.

Shire PLC has published results from its Phase 1b lanadelumab study in the New England Journal of Medicine. Read More »

CVS Health opens MinuteClinic in nation's capital

American Pharmacy News Reports | May 1, 2017
The new clinic in Washington will be open weekdays with no appointments necessary.

CVS Health recently opened a MinuteClinic walk-in medical clinic inside the CVS Pharmacy store on K Street NW in Washington D.C. Read More »

Allergan raises awareness of Chronic Dry Eye

American Pharmacy News Reports | Apr 29, 2017
The redness, itching and watering eyes associated with Chronic Dry Eye can often send the wrong message.

Allergan recently announced a new campaign to raise awareness for Chronic Dry Eye, using the slogan “before we had our voice, we had eyes.” Read More »

Allergan to sponsor Alzheimer's Foundation of America's education tour

American Pharmacy News Reports | Apr 29, 2017
The tour will involve educational conferences that give individuals a chance to learn from dementia and caregiver experts.

Allergan will sponsor the Alzheimer's Foundation of America's (AFA) "15th Anniversary National Educating America Tour” that honors AFA’s 15 years of Alzheimer’s education. Read More »

Tivantinib's Phase III study fails to meet primary endpoint

American Pharmacy News Reports | Apr 29, 2017
The METIV-HCC Phase 3 study evaluated tivantinib for treating patients with MET-overexpressing, inoperable HCC.

ArQule Inc. and Daiichi Sankyo's METIV-HCC Phase 3 study of tivantinib in hepatocellular carcinoma failed to meet its primary endpoint of improving overall survival. Read More »

Report on asthma management taps allergy immunotherapy as treatment

American Pharmacy News Reports | Apr 29, 2017
ALK’s ACARIZAX is approved in 12 European countries and Australia.

The Global Initiative for Asthma’s report, Global Strategy for Asthma Management and Prevention, is recommending allergy immunotherapy as a treatment option. Read More »

Genentech sees positive results for Phase II study combining Tecentriq

American Pharmacy News Reports | Apr 29, 2017
Genentech is also evaluating the combination of Tecentriq and Avastin compared to sunitinib in a Phase III study.

Genentech's Phase II Mmotion150 study for Tecentriq compared Tecentriq plus Avastin and Tecentriq monotherapy to sunitinib alone reinforced the potential of the combination drug for the treatment of patients with previously untreated, locally advanced or metastatic renal cell carcinoma. Read More »

Albertson's trains almost 3,000 pharmacists to administer naloxone

American Pharmacy News Reports | Apr 28, 2017
Many states Albertson's operates in allow pharmacies to dispense Naxolone without prescription.

Albertson’s Cos. have trained close to 3,000 pharmacists in administering naloxone to treat patients overdosing on opioids. Read More »

GSK, Innoviva see positive results in Relvar Ellipta asthma study

American Pharmacy News Reports | Apr 28, 2017

GlaxoSmithKline (GSK) and Innoviva Inc. recently released positive results for a study evaluating Relvar Ellipta in treating asthma. Read More »

  • «
  • 1
  • 2
  • ...
  • 47
  • 48
  • 49 (current)
  • 50
  • 51
  • ...
  • 168
  • 169
  • »
Trending

Scott Newman, Chairman, Pharmacists United for Truth and Transparency

Pharmacists United for Truth and Transparency: PBMs are the ‘primary driver of high drug prices in the U.S.’

Dr. Gerard Acloque, Doctor for Florida Concierge Medicine & Wellness

Doctor on Eli Lilly compounding pharmacy lawsuit: 'We are now left with very little options outside the branded medications'

Sazan Sylejmani, Owner & Pharmacy Manager of Westmont Pharmacy

Monty's Home Medical highlights benefits of tailored compounded medications

Craig Brockie, Founder & CEO of Ultimate Health Solutions

Ultimate Health Solutions founder on Patients First: 'Our healthcare system doesn't reward health'

 Jeff Harrell Board President

NCPA comments on Trump's executive order concerning drug pricing

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up